Deal facts
- Buyer
- Sunstring Ltd
- Target
- A.M.S 2000 Trading Impex SRL
- Deal value
- Not disclosed
- Announced
- 2 January 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- Israel
- Consideration
- Not stated
Sources
Sunstring Ltd has agreed to acquire the assets of A.M.S 2000 Trading Impex SRL, a diagnostics distributor based in Israel, in a transaction structured as an asset sale. The deal was announced on 2 January 2026, following its completion on 31 December 2025. While the specific financial terms of the acquisition remain undisclosed, the transaction represents a significant strategic move within the diagnostics sector. The target operates as a key distributor in the Israeli market, providing essential diagnostic products and services to local healthcare providers.
The transaction has been formally completed, marking the end of the acquisition process. Regulatory approvals were secured prior to the finalisation of the deal, allowing for the immediate transfer of assets and operations. Sunstring Ltd now assumes full ownership of the acquired business assets, integrating them into its existing portfolio. This acquisition strengthens the buyer's market position in the region without requiring a full corporate merger. The parties have confirmed that all necessary legal and administrative requirements have been satisfied to finalise the sale.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Sunstring Ltd to acquire A.M.S 2000 Trading Impex SRL
{ "headline": "Completion of Sale of Diagnostics Distributor", "issuer": "BATM Advanced Communications Ltd. (BVC)", "announcement_date": "2026-01-02T07:00:00", "category_code": "Class 2 Disposal", "body": "Disclaimer* \n\n LEI: 213800FLQUB9J289RU66 \n\n 2 January 2026 \n\n \n\n BATM Advanced Communications Limited \n\n (\"BATM\" or \"the Group\") \n\n \n\n Completion of Sale of Di
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Laboratory Corporation of America Holdings to acquire BioReference Health, LLC
Laboratory Corporation of America Holdings has agreed to acquire BioReference Health, LLC in a transaction valued at 722 million US dollars. The deal, announced on 14 Oc…
- Buyer
- Laboratory Corporation of America Holdings
- Target
- BioReference Health, LLC
- Deal value
- USD 722,000,000
- Deal type
- asset sale
Silo Pharma, Inc. to acquire Larry King
Silo Pharma, Inc. has completed the acquisition of assets from Larry King. The transaction, which was announced on 14 October 2026, was finalized on 13 October 2026. Bot…
- Buyer
- Silo Pharma, Inc.
- Target
- Larry King
- Deal value
- Not disclosed
- Deal type
- asset sale
Silo Pharma, Inc. to acquire Norsight Consulting Inc.
Silo Pharma, Inc. has agreed to acquire assets from Norsight Consulting Inc. in a transaction announced on 2 October 2026. Both companies are based in the United States…
- Buyer
- Silo Pharma, Inc.
- Target
- Norsight Consulting Inc.
- Deal value
- Not disclosed
- Deal type
- asset sale
JOINT Corp to acquire The Joint Franchises San Antonio, LLC, The Joint Franchises DFW, LLC, The Joint Franchises Houston, LLC, The Joint Franchises Austin, LLC, and The Joint Franchises Texas, Ltd.
JOINT Corp has agreed to acquire a portfolio of five Texas-based entities from The Joint franchise network. The transaction, announced and completed on 1 October 2026, i…
- Buyer
- JOINT Corp
- Target
- The Joint Franchises San Antonio, LLC, The Joint Franchises DFW, LLC, The Joint Franchises Houston, LLC, The Joint Franchises Austin, LLC, and The Joint Franchises Texas, Ltd.
- Deal value
- USD 8,000,000
- Deal type
- asset sale
Element Biosystems, LLC to acquire Standard BioTools Inc.
Element Biosystems, LLC has agreed to acquire Standard BioTools Inc. in a cash asset sale. The transaction was announced on 30 September 2026 and is valued at five milli…
- Buyer
- Element Biosystems, LLC
- Target
- Standard BioTools Inc.
- Deal value
- USD 5,500,000
- Deal type
- asset sale
Buyer history
Sunstring Ltd
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive
